Neuropathological findings after continuous intrathecal administration of S(+)-ketamine for the management of neuropathic cancer pain

Pain

Volumn 117, Issue 1-2, 2005, Pages 231-235

  Vranken, J H ^a   Troost, D ^a   Wegener, J T ^a   Kruis, M R ^a   Van Der Vegt, M H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cancer pain; Histopathology; Intrathecal pain treatment; S(+) ketamine; Spinal cord

Indexed keywords

BUPIVACAINE; CLONIDINE; KETAMINE; MORPHINE;

ADULT; ANALGESIA; ARTICLE; CANCER PAIN; CASE REPORT; DRUG EFFICACY; FEMALE; GLIOSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROGLIA; NERVE CELL; NERVE ROOT; NEUROPATHIC PAIN; NEUROPATHOLOGY; NEUROTOXICITY; PRIORITY JOURNAL; SPINAL CORD; SPINAL CORD LESION; TREATMENT OUTCOME; UPREGULATION;

ANALGESICS; FEMALE; HUMANS; KETAMINE; MIDDLE AGED; NEOPLASMS; PAIN; POSTMORTEM CHANGES; SPINAL CORD;

EID: 28844466409     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2005.06.014     Document Type: Article

References (25)

1. B. Adornato, and P. Lampert Status spongiosus of nervous tissue. Electron microscopic studies Acta Neuropathol 19 1971 271 289
2. N. Almenrader, M. Passariello, G. D'Amico, R. Haiberger, and P. Pietropaoli Caudal additives for postoperative pain management in children: S(+)-ketamine and neostigmine Pediatr Anesth 15 2005 143 147
3. E. Aronica, E.A. van Vliet, O.A. Mayboroda, D. Troost, F.H. da Silva, and J.A. Gorter Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy Eur J Neurosci 12 2000 2333 2344
4. J.C. Eisenach, and T.L. Yaksh Epidural ketamine in healthy children - what's the point? Anesth Analg 96 2003 626 633
5. C.L. Errando, C. Sifre, S. Moliner, J.C. Valia, O. Gimeno, A. Minguez, and P. Boils Subarachnoid ketamine in swine: pathological findings after repeated doses - acute toxicity studies Reg Anesth Pain Med 24 1999 146 152
6. N.B. Farber, S.H. Kim, K. Dikranian, X.P. Jiang, and C. Heinkel Receptor mechanisms and circuitry underlying NMDA anatagonist neurotoxicity Mol Psychiatry 7 2002 32 43
7. S.J. Hassenbusch, and R.K. Portenoy Current practices in intraspinal therapy-a survey of clinical trends and decision making J Pain Symptom Manage 20 2000 S4 S11
8. G. Hocking, and M.J. Cousins Ketamine in chronic pain: an evidence-based review Anesth Analg 97 2003 1730 1739
9. P.S. Hodgson, J.M. Neal, J.E. Pollock, and S.S. Liu The neurotoxicity of drugs given intrathecally (spinal) Anesth Analg 88 1999 797 809
10. N. Karpinsky, J. Dunn, L. Hansen, and E. Masliah Subpial vacuolar myelopathy after intrathecal ketamine: report of a case Pain 73 1997 103 105
11. G.W. Kreutzberg, W.F. Blakemore, and M.B. Graeber Cellular pathology of the central nervous system D.I. Graham P.L. Lantos Ellenhorn's medical toxicology: diagnosis and treatment of human poisening 1997 Williams and Wilkins Baltimore, MD 1179 1180
12. M.H. Levy Pharmacological treatment of cancer pain N Eng J Med 10 1996 1124 1132
13. J.M. Malinovsky, J.Y. Lepage, A. Cozian, J.M. Mussini, M. Pinaudt, and R. Souron Is ketamine or its preservative responsible for neurotoxicity in rabbit? Anesthesiology 78 1993 109 115
14. S. Sator-Katzenschlager, E. Deusch, P. Maier, A. Spacek, and H.G. Kress The long-term antinociceptive effect of intrathecal S(+)-ketamine in a patient with established morphine tolerance Anesth Analg 93 2001 1032 1034
15. M. Sjöberg, P.A. Karlsson, C. Nordborg, A. Wallgren, P. Nitescu, L. Appelgren, L.E. Linder, and I. Curelaru Neuropathologic findings after long-term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients Anesthesiology 76 1992 173 186
16. M. Stotz, H.P. Oehen, and H. Gerber Histological findings after long-term infusion of intrathecal ketamine for chronic pain J Pain Symptom Manage 18 1999 223 228
17. K. Subramaniam, B. Subramaniam, and R.A. Steinbrook Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review Anesth Analg 99 2004 482 495
18. E.E. Ubogu, S.M. Sagar, A.J. Lerner, B.N. Maddux, J.I. Suarez, and M.A. Werz Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity Epilepsy Behav 4 2003 70 75
19. J.H. Vranken, M.H. van der Vegt, J.E. Kal, and M.R. Kruis Treatment of neuropathic cancer pain with continuous intrathecal administration of S(+)-ketamine Acta Anaesthesiol Scand 48 2004 249 252
20. M.F.M. Wagemans, P. van der Valk, E.M. Spoelder, W.W.A. Zuurmond, and J.J. de Lange Neurohistopathological findings after continuous inthrathecal administration of morphine or a morphine/bupivacine mixture in cancer pain patients Acta Anaesthesiol Scand 41 1997 1033 1038
21. S.M. Walker, L.C. Goudas, M.J. Cousins, and D.B. Carr Combination spinal analgesic chemotherapy: a systemic review Anesth Analg 95 2002 674 715
22. C. Wang, N. Sadovova, X. Fu, L. Schmued, A. Scallet, J. Hanig, and W. Slikker The role of the N-methyl-d-Aspartate receptor in ketamine-induced apoptosis in rat forebrain culture Neuroscience 132 2005 967 977
23. T.L. Yaksh Epidural ketamine: a useful, mechanistically novel adjuvant for epidural morphine? Reg Anesth 21 1996 508 513
24. T.L. Yaksh, M.L. Rathbun, and J.C. Provencher Preclinical safety evaluation for spinal drugs T.L. Yaksh Spinal drug delivery 1999 Elsevier Amsterdam 417 437
25. A. Yamashita, M. Matsumoto, S. Matsumoto, M. Itoh, K. Kawai, and T. Sakabe A comparison of the neurotoxic effects on the spinal cord of tetracaine, lidocaine, bupivacaine, and ropivacaine administered intrathecally in rabbits Anesth Analg 97 2003 512 519